4/A: Q32 Bio Director Receives Stock Grant
Insider Transaction (Form 4/A)
Sven Ante Lundberg, a Director of Q32 Bio Inc., received 10,826 shares of common stock on June 12, 2026.
Summary
- Grant/award: acquired 10,826 Stock Option (Right to Buy) on June 12, 2026; holds 10,826 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Sven Ante Lundberg — Director
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-06-12 | Grant/award | Stock Option (Right to Buy) | 10,826 | — | — | 10,826 |
Key Dates
| Date | Description |
|---|---|
| 2026-06-12 | Grant/award (10,826 shares) |
Keywords
insider transaction, Form 4/A, QTTB, Q32 Bio Inc., neutral, Sven Ante Lundberg
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.